SCHEMBL29339573

SCHEMBL29339573

Cc1cc(COC(=O)C(C)C)ccn1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ADAMTS4 O75173 1/20 0.45
MMP13 P45452 1/20 0.45
GRM5 P41594 1/20 0.40
POLB P06746 3/20 0.39
KCNQ2 O43526 1/20 0.38
ALDH1A1 P00352 4/20 0.38
KDM4E B2RXH2 1/20 0.38
UHRF1 Q96T88 1/20 0.37
FFAR1 O14842 1/20 0.37
ROCK2 O75116 1/20 0.36
AOC3 Q16853 1/20 0.36
ALOX15 P16050 1/20 0.36
CYP3A4 P08684 1/20 0.36
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
KMT2A Q03164 1/20 0.35
SMARCA2 P51531 1/20 0.35
SMARCA4 P51532 1/20 0.35
CYP19A1 P11511 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL501663 0.83 ALDH1A1 (0.50) ADAMTS4MMP13GRM5POLBKCNQ2
SCHEMBL29341638 0.83 GABRP (0.53) POLBKDM4EROCK2KMT2A
SCHEMBL20448974 0.82 GRM5 (0.41) ADAMTS4MMP13GRM5POLBKCNQ2
SCHEMBL6732496 0.78 CYP19A1 (0.50) POLBALDH1A1KDM4EROCK2MAPT
SCHEMBL26474046 0.77 GABRP (0.41) ADAMTS4MMP13KCNQ2UHRF1FFAR1
SCHEMBL26240902 0.75 ALDH1A1 (0.47) POLBALDH1A1KDM4EALOX15CYP3A4
SCHEMBL29339578 0.75 POLB (0.50) POLBALDH1A1KDM4EROCK2ALOX15
SCHEMBL28319641 0.75 UHRF1 (0.48) ADAMTS4MMP13GRM5KCNQ2UHRF1
SCHEMBL15762727 0.74 ALDH1A1 (0.48) POLBALDH1A1KDM4EROCK2ALOX15
SCHEMBL22310964 0.74 PTGDR2 (0.38) ADAMTS4MMP13FFAR1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240239774-A1 SOLUBLE ADENYLYL CYCLASE (SAC) INHIBITORS AND USES THEREOF CORNELL UNIVERSITY (US) 2024-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240239774-A1 SOLUBLE ADENYLYL CYCLASE (SAC) INHIBITORS AND USES THEREOF UACA, ADCYAP1R1, ADCY1 ADAMTS4 1938/4885MMP13 3369/4885GRM5 3720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.